Clin2
NCT02394626Possibly a fitRecruiting

Surgery for glioblastoma that has come back

Glioblastoma

Part of Cancer clinical trials.

This trial studies whether operating on a brain tumor that has returned can help people with recurrent glioblastoma. It focuses on people whose scans suggest surgery is safe for important speech and movement brain areas.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old and can give informed consent
  • You previously had glioblastoma removed by surgery, confirmed by lab tissue testing
  • Your tumor has been treated with standard radiation, with or without temozolomide (a chemotherapy medicine)
  • Your disease has had its first return/progression, not within 3 months after finishing radiation
  • Brain MRI suggests the tumor can be removed safely without lasting problems with speech or movement
  • Your health and daily functioning are good (KPS 70 or higher)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06283927Recruiting
Surgery vs. medical care for recurrent glioblastoma

This trial compares surgery to the best non-surgical treatment for people whose glioblastoma has come back. The goal is to see which approach helps people live longer with a better quality of life.

San Francisco, California
NCT07173829Recruiting
Study of why glioblastoma comes back

This trial collects tumor samples to study what causes glioblastoma to return. It may help scientists find better treatments.

Bordeaux
NCT05432518Recruiting· Early Phase 1
Pilot study for surgery and new medicine in recurrent glioblastoma

This early study looks at a treatment plan (including resection/surgery and an added medicine) for glioblastoma that has come back after standard therapy. The goal is to see how well it controls tumor growth and whether it is tolerable.

Calgary, Alberta
NCT03970447Recruiting· Phase 2/Phase 3
Testing several treatment options for new or returning glioblastoma

This trial studies different treatment regimens for people with glioblastoma that is either newly diagnosed or has come back. It aims to find which treatment approach works best for controlling the tumor and improving outcomes.

Birmingham, Alabama
NCT07263438Recruiting· Phase 2
Trimipramine, atezolizumab, and bevacizumab for recurrent glioblastoma

This trial tests a combination of three drugs—trimipramine (an antidepressant), atezolizumab (an immunotherapy), and bevacizumab (a targeted therapy)—in people whose glioblastoma has come back after initial treatment. The goal is to see if this mix can help shrink the tumor or slow its growth.

Basel, Basel
NCT06273176Recruiting
Surgery with or without brain mapping for recurrent glioblastoma

This study is testing whether using a special brain-mapping technique during surgery helps people with recurrent glioblastoma. It compares standard surgery to surgery with mapping to see if it leads to better outcomes for tumors near important brain areas.

San Francisco, California

Hear when a new Glioblastoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.